Yifan Xinfu Pharmaceutical Co Ltd Capital Reinvestment Ratio
Yifan Xinfu Pharmaceutical Co Ltd capital reinvestment ratio. Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Capital Reinvestment Ratio of 4.60x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥40.18 Million) in capital expenditures (CN¥184.68 Million). Check Yifan Xinfu Pharmaceutical Co Ltd (002019) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Capital reinvestment ratio of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. This chart tracks Yifan Xinfu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. Also explore 002019 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Yifan Xinfu Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2003–2025)
Yifan Xinfu Pharmaceutical Co Ltd capital reinvestment ratio by year from 2003 to 2025. For the full cash flow conversion analysis, see Yifan Xinfu Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | CN¥458.37 Million | CN¥559.23 Million | ▲ +24.4% |
| 2024 | 0.98x | CN¥640.73 Million | CN¥628.16 Million | ▼ -32.2% |
| 2023 | 1.45x | CN¥348.58 Million | CN¥504.09 Million | ▲ +25.9% |
| 2022 | 1.15x | CN¥472.07 Million | CN¥542.27 Million | ▼ -39.5% |
| 2021 | 1.90x | CN¥301.23 Million | CN¥571.74 Million | ▲ +194.0% |
| 2020 | 0.65x | CN¥1.11 Billion | CN¥715.71 Million | ▼ -30.1% |
| 2019 | 0.92x | CN¥937.24 Million | CN¥866.07 Million | ▲ +48.4% |
| 2018 | 0.62x | CN¥1.17 Billion | CN¥729.21 Million | ▲ +45.2% |
| 2017 | 0.43x | CN¥1.13 Billion | CN¥485.86 Million | ▲ +27.7% |
| 2016 | 0.34x | CN¥855.85 Million | CN¥287.50 Million | ▼ -37.8% |
| 2015 | 0.54x | CN¥401.96 Million | CN¥217.15 Million | ▼ -15.7% |
| 2014 | 0.64x | CN¥139.74 Million | CN¥89.51 Million | ▼ -70.3% |
| 2013 | 2.15x | CN¥34.32 Million | CN¥73.95 Million | ▼ -4.8% |
| 2012 | 2.26x | CN¥29.88 Million | CN¥67.64 Million | ▼ -12.3% |
| 2009 | 2.58x | CN¥58.61 Million | CN¥151.27 Million | ▲ +75.6% |
| 2008 | 1.47x | CN¥83.31 Million | CN¥122.46 Million | ▲ +112.5% |
| 2007 | 0.69x | CN¥248.71 Million | CN¥172.06 Million | ▼ -60.8% |
| 2006 | 1.77x | CN¥32.62 Million | CN¥57.62 Million | ▼ -27.3% |
| 2005 | 2.43x | CN¥24.12 Million | CN¥58.63 Million | ▲ +16.4% |
| 2004 | 2.09x | CN¥33.59 Million | CN¥70.14 Million | ▼ -49.6% |
| 2003 | 4.14x | CN¥12.65 Million | CN¥52.44 Million | — |